YOLFTbeta
DBV Technologies S.A.

DBV Technologies S.A.

DBV · PA · Healthcare / Biotechnology

1.97EUR-0.15 (-7.22%)

Price History

Full chart

Market Stats

Previous Close2.12
Open2.10
Day Range1.90 – 2.11
52-Week Range1.90 – 4.50
Volume1.26M
Market Cap598.32M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.62
Dividend Yield0.00%
Beta-0.23
50-Day Avg2.31
200-Day Avg3.09

About

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Daniel Tassé
  • Employees170
  • HeadquartersBAtiment IRO, Châtillon, France, 92320, France
  • Websitehttps://www.dbv-technologies.com

Leadership

  • Mr. Daniel TasséCEO & Director · b. 1960
  • Ms. Virginie Simone Jeanine Verrechia Boucinha M.B.A.Chief Financial Officer · b. 1969
  • Dr. Pharis Mohideen M.D.Chief Medical Officer · b. 1965
  • Dr. Kevin P. Malobisky M.S., Ph.D., R.A.C.Chief Operations Officer
  • Mr. Jonathan NeelyVP & Head of Investor Relations
  • Ms. Michele F. RobertsonChief Legal Officer
  • Mr. James BriggsChief Human Resources Officer · b. 1972
  • Mr. Kevin TrappChief Commercial Officer · b. 1967
  • Alan KerrSenior VP & Head of Global Regulatory Affairs
  • Mr. Pascal WotlingChief External Manufacturing & Supply Chain Officer

Financials

Income Statement

Currency: USD2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue245.00K115.00K164.00K179.00K213.05K297.52K333.43K332.67K240.98K10.40M13.63M16.64M14.71M11.28M5.71M25.07M15.73M4.15M5.64M
Growth (%)--53.06%+42.61%+9.15%+19.02%+39.65%+12.07%-0.23%-27.56%+4214.60%+31.10%+22.07%-11.61%-23.33%-49.38%+339.18%-37.26%-73.61%+35.77%
Cost of Revenue2.69M2.48M2.59M83.00K109.96K141.55K187.74K215.14K152.70K1.42M3.43M5.03M3.09M18.82M9.27M20.30M-4.57M680.00K18.34M
Gross Profit----103.09K155.96K145.69K117.54K88.28K-1.42M-3.43M-5.03M-3.09M-18.82M-3.57M4.77M15.73M4.15M-18.34M
Gross Margin----48.39%52.42%43.69%35.33%36.63%-13.61%-25.19%-30.25%-21.01%-166.88%-62.46%19.02%100.00%100.00%-325.38%
Operating Expense----12.38M23.20M36.74M39.00M54.42M126.59M200.65M222.14M189.71M175.98M95.05M101.40M92.16M120.74M140.58M
Operating Income-----12.27M-23.04M-36.59M-38.89M-54.34M-128.00M-204.08M-227.17M-192.80M-194.80M-98.61M-96.63M-76.43M-116.59M-158.92M
Operating Margin-----5760.35%-7745.10%-10974.91%-11689.15%-22547.53%-1231.08%-1497.18%-1365.31%-1310.87%-1727.55%-1727.65%-385.47%-485.97%-2808.70%-2819.68%
EBITDA-----11.88M-21.68M-29.56M-36.00M-53.62M-126.29M-176.90M-206.16M-181.37M-162.74M-79.77M-76.33M-79.95M-109.05M-140.58M
EBITDA Margin-----5575.59%-7286.80%-8864.41%-10821.11%-22250.70%-1214.58%-1297.78%-1239.01%-1233.11%-1443.28%-1397.52%-304.50%-508.30%-2626.96%-2494.30%
Net Income-----12.24M-22.20M-35.41M-37.90M-53.30M-126.35M-207.90M-227.00M-195.20M-195.68M-97.81M-96.27M-72.73M-113.92M-152.94M
Net Income Margin-----5744.65%-7462.73%-10619.61%-11393.08%-22115.85%-1215.17%-1525.17%-1364.27%-1327.17%-1735.35%-1713.54%-384.05%-462.40%-2744.35%-2713.59%
R&D---5.06M11.28M19.76M31.85M33.37M40.84M86.96M148.13M146.49M129.00M124.61M70.34M75.50M60.22M89.34M111.15M
R&D as % of Total Revenue---2827.37%5296.19%6641.06%9552.57%10032.07%16947.53%836.36%1086.69%880.38%877.06%1105.07%1232.24%301.18%382.90%2152.30%1972.09%
Interest Expense000072.00K43.01K44.59K162.96K159.62K17.65K4.68M479.76K1.79M887.89K583.76K427.00K---
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%33.80%14.46%13.37%48.98%66.24%0.17%34.34%2.88%12.18%7.87%10.23%1.70%---

Balance Sheet

Currency: USD2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets7.84M3.98M6.79M11.57M26.57M73.33M84.80M197.96M409.53M317.16M250.28M234.76M306.90M333.87M146.72M246.50M183.04M65.66M233.75M
Total Liabilities2.20M2.11M2.19M3.01M6.79M6.49M10.71M15.74M25.30M49.26M67.40M68.98M88.86M81.87M47.45M52.00M43.02M38.27M64.96M
Total Equity5.63M1.87M4.60M8.57M19.79M66.84M74.09M182.22M384.24M267.90M182.88M165.78M218.05M252.01M99.27M194.50M140.19M27.39M168.79M
Cash5.47M1.68M4.41M9.03M19.49M65.43M72.27M180.86M385.79M282.93M194.08M167.81M218.64M240.80M77.30M209.20M141.37M32.46M194.19M
Total Debt----1.39M2.08M2.74M6.69M6.01M5.28M6.46M5.24M31.35M40.63M9.74M10.05M5.67M6.95M7.99M
Net Debt-----18.10M-63.35M-69.52M-174.17M-379.78M-277.65M-187.62M-162.57M-187.28M-200.17M-67.57M-199.18M-135.70M-25.50M-186.20M

Cash Flow

Currency: USD2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--10.36M-17.80M-24.31M-32.45M-31.93M-65.68M-160.91M-186.74M-163.34M-165.61M-108.24M-55.70M-79.65M-104.47M-126.12M
Investing Cash Flow--1.76M-629.23K-2.58M-1.73M-6.38M-9.16M-11.03M-11.81M-6.43M-2.87M-433.00K-100.00K-786.62K-757.00K-1.42M
Financing Cash Flow9.13M16.35M63.30M29.78M152.81M287.53M1.84M402.58K178.62M232.32M149.55M274.00K194.10M6.77M587.00K287.44M
Capital Expenditure48.00K1.21M616.73K2.15M1.53M5.38M9.05M10.62M6.49M6.35M2.76M918.00K754.00K677.00K2.34M553.69K
Free Cash Flow--11.57M-18.42M-26.46M-33.99M-37.31M-74.73M-171.53M-193.23M-169.70M-168.37M-109.16M-56.45M-80.33M-106.81M-126.68M
Dividends Paid----4.94M1.03M0000303.00K-----
FCF to OCF-111.67%103.46%108.84%104.73%116.84%113.78%106.60%103.48%103.89%101.67%100.85%101.35%100.85%102.24%100.44%
Dividend Paid to FCF-----14.53%-2.77%0.00%0.00%0.00%0.00%-0.18%-----

Earnings

Report DateJul 28, 2014Mar 25, 2015Apr 29, 2015Jul 27, 2015May 31, 2016Jul 28, 2016Nov 3, 2016Mar 15, 2017Apr 28, 2017Jul 28, 2017Oct 31, 2017Mar 14, 2018Apr 27, 2018Sep 7, 2018Oct 30, 2018Mar 5, 2019May 24, 2019Aug 1, 2019Oct 31, 2019Mar 4, 2020Apr 30, 2020Jul 21, 2020Oct 30, 2020Mar 11, 2021May 3, 2021Aug 2, 2021Oct 26, 2021Mar 3, 2022May 2, 2022Aug 1, 2022Nov 3, 2022Mar 3, 2023May 4, 2023Jul 31, 2023Oct 31, 2023Mar 8, 2024May 7, 2024Jul 30, 2024Nov 6, 2024Mar 24, 2025Apr 30, 2025Jul 29, 2025Oct 28, 2025Mar 26, 2026Apr 30, 2026Jul 16, 2026Oct 28, 2026
EPS Estimate0.000.00-0.000.000.000.000.000.000.000.00-2.04-2.04-1.70-1.74-1.44-2.42-1.88-1.88-1.98-0.92-0.90-1.10-1.89-0.50-0.48-0.34-0.45-0.40-0.27-0.24-0.18-0.27-0.28-0.27-0.33-0.33-0.20-0.33-0.21-0.04-0.29-0.21-0.09-0.02-0.08-0.08
EPS Actual0.000.00-0.32-0.430.000.00-2.09-2.90-3.40-2.48-3.86-2.16-2.00-1.70-1.74-1.44-2.42-1.88-1.881.20-0.92-3.12-1.10-2.51-0.89-0.94-0.76-0.23-0.57-0.68-0.37-0.18-0.40-0.47-0.32-0.11-0.52-0.34-0.29-0.22-0.25-0.13-0.10-0.10-0.10-0.05-
Surprise------------5.88%1.96%0.00%0.00%0.00%0.00%0.00%0.00%160.61%0.00%-246.67%0.00%-32.80%-78.00%-95.83%-123.53%48.89%-42.50%-151.85%-54.17%0.00%-48.15%-67.86%-18.52%67.24%-57.58%-70.00%12.24%-4.52%-496.90%55.17%52.38%-11.11%-305.98%37.50%-
Timing-Pre-marketPre-marketPre-marketPre-marketPre-market-Pre-market-Pre-market-Pre-market-Pre-marketPre-marketAfter-hoursAfter-hoursAfter-hours-After-hours-Pre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap598.32M
Enterprise Value539.62M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales118.81
Price / Book4.89
EPS-0.62
Book Value0.4813
Revenue (TTM)5.04M
Gross Profit (TTM)5.04M
EBITDA-174.76M
Profit Margin0.00%
Operating Margin-7228.57%
Return on Equity-142.68%
Return on Assets-60.61%
Shares Outstanding314.24M
Shares Float174.70M
Beta-0.23
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%